News & Events about Biotech Acquisition Co Cl A.
Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement PR Newswire NEW YORK and SOUTH SAN FRANCISCO, Calif., June 13, 2022 NEW YORK...
Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business...
Business Wire
8 months ago
Blade Therapeutics, Inc., a biopharmaceutical company focused on developing cutting-edge treatments for debilitating fibrotic and neurodegenerative diseases, today announced new data from preclinical studies that highlight the differentiating characteristics of cudetaxestat, an investigational...
Business Wire
8 months ago
Blade Therapeutics, Inc., a biopharmaceutical company focused on developing cutting-edge treatments for debilitating fibrotic and neurodegenerative diseases, today announced encouraging data from phase 1 and preclinical DDI studies of cudetaxestat, an investigational non-competitive autotaxin...
Globe Newswire
10 months ago
NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased ...